Atea Pharmaceuticals (AVIR) Net Equity Issued and Repurchased (2020)
Atea Pharmaceuticals' (AVIR) quarterly Net Equity Issued and Repurchased came in at $107.5 million in Q4 2020.
Atea Pharmaceuticals (AVIR) Net Equity Issued and Repurchased (2020) Analysis & Trends
Atea Pharmaceuticals' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $107.5 million for Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Atea Pharmaceuticals | 376.19 Mn | 376.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 107.49 Mn |
| Dec 31, 2020 | 107.49 Mn |